Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E‐selectin in patients with wegener's granulomatosis. Relationship to disease activity and relevance during followup
Open Access
- 1 December 1994
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 37 (8) , 1228-1235
- https://doi.org/10.1002/art.1780370818
Abstract
Objective, To assess the value of measuring serum levels of soluble intercellular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1 (sVCAM-1), and soluble E-selectin for monitoring disease activity in Wegener's granulomatosis (WG). Methods. A sandwich enzyme-linked immunosorbent assay was used to measure levels of soluble adhesion molecules at the time of diagnosis in 22 consecutive patients with WG, in 12 WG patients studied serially prior to disease relapse, at the time of upper airways infection in 18 patients with inactive WG, and in 57 controls. Disease activity was assessed by disease activity score and C-reactive protein levels. Results. At diagnosis of WG, sICAM-1 and sVCAM-1 levels were significantly elevated and correlated with disease activity. At the time of relapse, a significant increase in all 3 soluble adhesion molecules was found compared with levels at 6 months prior to relapse, but only sVCAM-1 levels were significantly elevated compared with those in controls. Levels of soluble adhesion molecules at the time of relapse did not differ from those measured during an upper airways infection without disease activity. Conclusion. Elevated serum levels of sICAM-1 and sVCAM-1 can be found in active WG and correlate with disease activity. However, their clinical relevance for followup is limited due to lack of sensitivity and specificity for WG disease activity.Keywords
This publication has 33 references indexed in Scilit:
- Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritisArthritis & Rheumatism, 1993
- Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosusClinical and Experimental Immunology, 1993
- Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves’ ophthalmopathy and thyroid diseasesClinical and Experimental Immunology, 1993
- Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. lack of correlation with levels of circulating vascular cell adhesion molecule 1Arthritis & Rheumatism, 1993
- Serum markers of T cell activation in relapses of Wegener's granulomatosisClinical and Experimental Immunology, 1993
- The Expression of Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1), Intercellular Adhesion Molecule-1 (ICAM-1), and Vascular Cell Adhesion Molecule-1 (VCAM-1) in Experimental Cutaneous Inflammation: A Comparison of Ultraviolet B erythema and Delayed HypersensitivityJournal of Investigative Dermatology, 1991
- Expression of VCAM-1 in the Normal and Diseased KidneyNephrology Dialysis Transplantation, 1991
- Adhesion of Human B Cells to Germinal Centers in Vitro Involves VLA-4 and INCAM-110Science, 1990
- Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.The Journal of cell biology, 1988
- Multiple Range and Multiple F TestsPublished by JSTOR ,1955